- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03467061
The Effect of Dietary Nitrate on the Oral Microbiome (Microbio)
May 26, 2021 updated by: University of Exeter
The Effect of Dietary Nitrate on the Oral Microbiota, Markers of Nitric Oxide Bioavailability and Cardiovascular Health in in Young and Older Adults
This study evaluates whether dietary manipulation of the oral microbiota modulates cardiovascular health through effects on nitric oxide bioavailability.
Study Overview
Status
Completed
Detailed Description
Nitric oxide is an important molecule for human health because it controls blood flow and blood pressure.
With aging, our ability to make nitric oxide gets worse and our blood pressure tends to increase.
We can help the body produce more nitric oxide by supplementing the diet with vegetables, such as beetroot juice, which contains high amounts of nitrate.
This has been shown to improve blood flow and blood pressure.
The bacteria inside our mouths play an important role in helping convert the ingested nitrate to nitric oxide.
The reason for this study is to find out whether there are differences in oral bacteria between young and older adults, and how the oral bacterial community and blood flow and blood pressure might change when diet is supplemented with natural, nitrate-rich beetroot juice and when we use antibacterial mouthwash.
This study will help us understand how the bacteria inside our mouths might be useful for keeping us healthy.
Study Type
Interventional
Enrollment (Actual)
101
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Devon
-
Exeter, Devon, United Kingdom
- Diabetes & Vascular Medicine Research Centre, Clinical Research Facility
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Healthy young (18-30 yr) and older adults (65-80 yr)
- Male and female
- Willing to undergo the experiments as detailed in the informed consent documentation
- Willing and capable of providing written, informed consent.
Exclusion Criteria:
- Individuals receiving medication for pulmonary, cardiovascular, or metabolic conditions, ulcerative colitis or renal disease
- Having an active oral disease or dentures
- Having resting BP >140/90 mmHg
- Having used antibiotics within 3 months
- Lacking willingness or capacity to give informed consent.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: BASIC_SCIENCE
- Allocation: RANDOMIZED
- Interventional Model: CROSSOVER
- Masking: QUADRUPLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
ACTIVE_COMPARATOR: Nitrate-rich beetroot juice
2 x 70mL concentrated juice per day for 14 days
|
concentrated beetroot juice
|
|
PLACEBO_COMPARATOR: Nitrate-depleted beetroot juice
2 x 70mL concentrated juice per day for 14 days
|
concentrated beetroot juice
|
|
OTHER: Antibacterial mouthwash
2 x 10mL antibacterial mouthwash per day for 14 days
|
2 x 10 mL antibacterial mouthwash per day for 14 days
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Quantity of nitrate -reducing bacteria
Time Frame: 14 days
|
Change in total quantity of nitrate-reducing bacteria as measured by sequencing bacterial 16S rRNA genes
|
14 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Nitric oxide bioavailability - plasma nitrite
Time Frame: 14 days
|
Change in nitrite concentration of plasma as measured by ozone-based chemiluminescence
|
14 days
|
|
Nitric oxide bioavailability - salivary nitrite
Time Frame: 14 days
|
Change in nitrite concentration of saliva as measured by ozone-based chemiluminescence
|
14 days
|
|
Nitric oxide bioavailability - plasma nitrate
Time Frame: 14 days
|
Change in nitrate concentration of plasma as measured by ozone-based chemiluminescence
|
14 days
|
|
Nitric oxide bioavailability - salivary nitrate
Time Frame: 14 days
|
Change in nitrate concentration of saliva as measured by ozone-based chemiluminescence
|
14 days
|
|
Blood pressure
Time Frame: 14 days
|
Change in systolic and diastolic BP
|
14 days
|
|
Flow mediated dilation
Time Frame: 14 days
|
Change in flow mediated dilation
|
14 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Andrew M Jones, PhD, University of Exeter
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
January 10, 2018
Primary Completion (ACTUAL)
May 6, 2021
Study Completion (ACTUAL)
May 6, 2021
Study Registration Dates
First Submitted
December 19, 2017
First Submitted That Met QC Criteria
March 14, 2018
First Posted (ACTUAL)
March 15, 2018
Study Record Updates
Last Update Posted (ACTUAL)
May 27, 2021
Last Update Submitted That Met QC Criteria
May 26, 2021
Last Verified
May 1, 2021
More Information
Terms related to this study
Other Study ID Numbers
- 1718/14
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiovascular Health
-
BIO-CAT Microbials, LLCBiofortis Clinical Research, Inc.CompletedImmune Health | Cardiovascular Health | Gastrointestinal Health | Digestive HealthUnited States
-
UMC UtrechtCompletedCardiovascular Health | Metabolic Health | Pulmonary HealthNetherlands
-
Lokman Hekim UniversityNot yet recruitingCardiovascular Risk Factors | Health Literacy | Cardiovascular HealthTurkey (Türkiye)
-
University of Texas Southwestern Medical CenterNot yet recruitingHealth Curiosity | Cardiovascular Health Risk Communication
-
Universidad Metropolitana de Ciencias de la EducacionNot yet recruitingMental Health | Physical Inactivity | Cardiovascular Health | Mental Health Care | Sedentary BehaviorsChile
-
Mayo ClinicCompletedCardiovascular Diseases | Cardiovascular HealthUnited States
-
National Yang Ming Chiao Tung UniversityNational Cheng-Kung University HospitalRecruitingMental Health | Lifestyle Intervention | Cardiovascular Health | Physical PerformanceTaiwan
-
JHSPH Center for Clinical TrialsNational Heart, Lung, and Blood Institute (NHLBI)RecruitingCardiovascular HealthUnited States
-
Northwestern UniversityNational Heart, Lung, and Blood Institute (NHLBI); University of Illinois at... and other collaboratorsCompletedCardiovascular HealthUnited States
-
Mayo ClinicActive, not recruitingCardiovascular HealthUnited States
Clinical Trials on Nitrate-rich beetroot juice
-
University of Colorado, BoulderActive, not recruitingChronic Kidney DiseaseUnited States
-
Oxford Brookes UniversityNot yet recruitingHypertension | Type 2 Diabetes Mellitus | Autonomic Nervous System DiseasesUnited Kingdom
-
University of FloridaCompletedCoronary Artery DiseaseUnited States
-
University of ExeterCompletedCognitive Change | Blood Pressure | Functional Capacity | Brain MetabolismUnited Kingdom
-
Bangor UniversityCompleted
-
University of Sao PauloCompletedCardiovascular Abnormalities | Steroid AbuseBrazil
-
Newcastle UniversityNot yet recruitingHeart Failure With Reduced Ejection Fraction
-
University of ReadingSaudi Cultural BureauCompletedNo Dental Disease | Non-smokingUnited Kingdom
-
University of VirginiaNot yet recruitingCoronary Microvascular Dysfunction (CMD) | Angina Patients With Non-obstructive Coronary Artery DiseaseUnited States
-
Universidad Autonoma de MadridUniversidad Politecnica de Madrid; Camilo Jose Cela UniversityCompletedNitrates | Nutrition | Physical Performance | Sport Physiology | Elite Athletes